- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 11.26M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $428.37K |
| Capex | Q1 2025 · Mar 31, 2024 | $1.55M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $17.61M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $18.04M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.97M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $9.65M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $19.81M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $19.76M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $45.23M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $44.47M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $66.8M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $65.45M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 10.96M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $5.14M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.04 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $0.04 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $3.37M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $693.38K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $650.36K |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $4.71M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $2.63M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $7.35M |